Form 4: Relay Therapeutics Executive Sells Shares to Cover Tax Obligations

Peter Rahmer, Chief Corporate Development Officer of Relay Therapeutics, sold 1,345 shares of common stock to cover income tax withholding obligations upon the vesting of restricted stock units.

Summary

• Peter Rahmer, Chief Corporate Development Officer of Relay Therapeutics, sold 1,345 shares of common stock on April 29, 2024.
• The sale was executed at a price of $6.38 per share.
• The transaction was to cover income tax withholding obligations related to the vesting of 5,505 restricted stock units (RSUs) on April 27, 2024.
• Following the transaction, Rahmer beneficially owns 513,334 shares of Relay Therapeutics, which includes 465,343 shares underlying RSUs.

Sentiment

Score: 6

Explanation: The document describes a routine transaction (sale of shares to cover tax obligations). It's neutral in tone and doesn't suggest any significant positive or negative sentiment regarding the company's prospects.

Industry Context

Sales of shares to cover tax obligations upon vesting of restricted stock units are a common practice among corporate executives. This transaction is a routine part of executive compensation and does not necessarily indicate a change in the executive's confidence in the company.

Stakeholder Impact

• The sale of shares by an executive could have a minor, temporary impact on the stock price, but is unlikely to have a significant long-term effect on shareholders.
• The transaction has no direct impact on employees, customers, suppliers, or creditors.

Key Dates